Last reviewed · How we verify
B.microti diagnostic blood tests
This diagnostic blood test detects Babesia microti parasites or antibodies to identify babesiosis infection in patients.
This diagnostic blood test detects Babesia microti parasites or antibodies to identify babesiosis infection in patients. Used for Diagnosis of Babesia microti infection (babesiosis).
At a glance
| Generic name | B.microti diagnostic blood tests |
|---|---|
| Also known as | proprietary in-house developed PCR and IFA Babesia doagnostic tests |
| Sponsor | Imugen |
| Modality | Biologic |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
B. microti diagnostic tests identify parasitemia through direct detection methods (blood smear microscopy, PCR) or serological detection of anti-Babesia microti antibodies. These tests enable early diagnosis of babesiosis, a tick-borne parasitic disease, allowing for timely treatment initiation and prevention of severe complications, particularly in immunocompromised or asplenic patients.
Approved indications
- Diagnosis of Babesia microti infection (babesiosis)
Common side effects
Key clinical trials
- Babesia Testing in Blood Donors (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- B.microti diagnostic blood tests CI brief — competitive landscape report
- B.microti diagnostic blood tests updates RSS · CI watch RSS
- Imugen portfolio CI